| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1039/B709549J |
| P698 | PubMed publication ID | 17912378 |
| P2093 | author name string | Andreas Kirschning | |
| Florian Taft | |||
| Tobias Knobloch | |||
| P2860 | cites work | Production of nikkomycins Bx and Bz by mutasynthesis with genetically engineered Streptomyces tendae Tü901 | Q77799907 |
| 6-Deoxy-α-L-talopyranosides fromStreptomyces sp. | Q78232900 | ||
| Structural Diversity of 1-O-Acyl α-L-Rhamnopyranosides by Precursor-Directed Biosynthesis withStreptomyces griseoviridis | Q113960350 | ||
| P433 | issue | 20 | |
| P921 | main subject | natural product chemistry | Q122207552 |
| natural product | Q901227 | ||
| metabolic engineering | Q6822347 | ||
| P304 | page(s) | 3245-3259 | |
| P577 | publication date | 2007-09-10 | |
| P1433 | published in | Organic and Biomolecular Chemistry | Q3355939 |
| P1476 | title | Total synthesis approaches to natural product derivatives based on the combination of chemical synthesis and metabolic engineering | |
| P478 | volume | 5 |
| Q40416482 | A Bio-Chemosynthetic Approach to Superparamagnetic Iron Oxide-Ansamitocin Conjugates for Use in Magnetic Drug Targeting |
| Q39029805 | A mutasynthesis approach with a Penicillium chrysogenum ΔroqA strain yields new roquefortine D analogues |
| Q41440279 | Advanced mutasynthesis studies on the natural α-pyrone antibiotic myxopyronin from Myxococcus fulvus |
| Q27012072 | Alkaloids from marine invertebrates as important leads for anticancer drugs discovery and development |
| Q39148991 | Bioactive derivatives of isopropylstilbene from mutasynthesis and chemical synthesis |
| Q38106149 | Bioengineering of plant (tri)terpenoids: from metabolic engineering of plants to synthetic biology in vivo and in vitro |
| Q35797661 | Broad substrate specificity of the amide synthase in S. hygroscopicus--new 20-membered macrolactones derived from geldanamycin |
| Q33634190 | Coalition of Biology and Chemistry for Ameliorating Antimicrobial Drug Discovery |
| Q37939609 | Combinatorial biosynthesis in plants: a (p)review on its potential and future exploitation |
| Q39428470 | Combined muta- and semisynthesis: a powerful synthetic hybrid approach to access target specific antitumor agents based on ansamitocin P3. |
| Q35856285 | Commentary: Toward a new focus in antibiotic and drug discovery from the Streptomyces arsenal |
| Q38398596 | Design and synthesis of analogues of natural products |
| Q42926304 | Engineered biosynthesis of antiprotealide and other unnatural salinosporamide proteasome inhibitors. |
| Q33641984 | Exploiting enzymatic promiscuity to engineer a focused library of highly selective antifungal and antiproliferative aureothin analogues |
| Q39816317 | Functional characterization of the cyclomarin/cyclomarazine prenyltransferase CymD directs the biosynthesis of unnatural cyclic peptides. |
| Q37801553 | Fungal cyclooligomer depsipeptides: from classical biochemistry to combinatorial biosynthesis. |
| Q38629855 | Genetic engineering of modular PKSs: from combinatorial biosynthesis to synthetic biology |
| Q27682818 | Heterologous expression and structural characterisation of a pyrazinone natural product assembly line |
| Q47759612 | Identification of a Thioesterase Bottleneck in the Pikromycin Pathway through Full-Module Processing of Unnatural Pentaketides. |
| Q38154186 | Industrial natural product chemistry for drug discovery and development. |
| Q37996334 | Merging chemical synthesis and biosynthesis: a new chapter in the total synthesis of natural products and natural product libraries |
| Q37789697 | Metabolic engineering of resveratrol and other longevity boosting compounds |
| Q37957116 | Microalgae in the postgenomic era: a blooming reservoir for new natural products |
| Q33590047 | Natural products as chemical probes |
| Q38922056 | New, non-quinone fluorogeldanamycin derivatives strongly inhibit Hsp90. |
| Q43246936 | Phosphopantetheinyl transferase inhibition and secondary metabolism |
| Q42954887 | Pilot-plant cultivation of Streptomyces griseus producing homologues of nonactin by precursor-directed biosynthesis and their identification by LC/MS-ESI |
| Q36117072 | Precursor directed biosynthesis of an orthogonally functional erythromycin analogue: selectivity in the ribosome macrolide binding pocket |
| Q57737206 | Precursor-Directed Biosynthesis of Polyketide and Nonribosomal Peptide Natural Products |
| Q44133451 | Precursor-directed biosynthesis of micacocidin derivatives with activity against Mycoplasma pneumoniae |
| Q42001924 | Preparation of new alkyne-modified ansamitocins by mutasynthesis |
| Q38944991 | Preparation of thermocleavable conjugates based on ansamitocin and superparamagnetic nanostructured particles by a chemobiosynthetic approach |
| Q37978431 | Ribosome-independent biosynthesis of biologically active peptides: Application of synthetic biology to generate structural diversity |
| Q33583746 | Sonogashira diversification of unprotected halotryptophans, halotryptophan containing tripeptides; and generation of a new to nature bromo-natural product and its diversification in water. |
| Q40183635 | Synthesis of Magnetic-Nanoparticle/Ansamitocin Conjugates-Inductive Heating Leads to Decreased Cell Proliferation In Vitro and Attenuation Of Tumour Growth In Vivo. |
| Q56536127 | Synthetic diversification of natural products: semi-synthesis and evaluation of triazole jadomycins |
| Q34915636 | Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy |
| Q38022529 | The generation of "unnatural" products: synthetic biology meets synthetic chemistry |
| Q34089152 | The interplay between mutasynthesis and semisynthesis: generation and evaluation of an ansamitocin library |
| Q37373526 | The structural diversity of acidic lipopeptide antibiotics |
| Q42128016 | Unprecedented deoxygenation at C-7 of the ansamitocin core during mutasynthetic biotransformations |
Search more.